Cargando…
Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in critically ill patients
INTRODUCTION: Metabolic alkalosis is a commonly encountered acid–base derangement in the intensive care unit. Treatment with the carbonic anhydrase inhibitor acetazolamide is indicated in selected cases. According to the quantitative approach described by Stewart, correction of serum pH due to carbo...
Autores principales: | Moviat, Miriam, Pickkers, Peter, van der Voort, Peter HJ, van der Hoeven, Johannes G |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550864/ https://www.ncbi.nlm.nih.gov/pubmed/16420662 http://dx.doi.org/10.1186/cc3970 |
Ejemplares similares
-
Acetazolamide-mediated decrease in strong ion difference accounts for the correction of metabolic alkalosis in intensive care unit patients
por: Pickkers, P, et al.
Publicado: (2005) -
The nature of unmeasured anions in critically ill patients
por: Moviat, Miriam AM, et al.
Publicado: (2008) -
Fluconazole and acetazolamide in the treatment of ectopic Cushing's syndrome with severe metabolic alkalosis
por: Schwetz, Verena, et al.
Publicado: (2015) -
Determination of 'unmeasured' anions in acidotic ICU patients
por: Pickkers, P, et al.
Publicado: (2006) -
Haloperidol prophylaxis in critically ill patients with a high risk for delirium
por: van den Boogaard, Mark, et al.
Publicado: (2013)